These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30188807)

  • 1. Quadrivalent Meningococcal Vaccine Uptake Among Men Who Have Sex With Men During a Meningococcal Outbreak in Los Angeles County, California, 2016-2017.
    Holloway IW; Wu ESC; Gildner J; Fenimore VL; Tan D; Randall L; Frew PM
    Public Health Rep; 2018; 133(5):559-569. PubMed ID: 30188807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal vaccine uptake among men who have sex with men in response to an invasive meningococcal C disease outbreak in Melbourne, Australia.
    Martín-Sánchez M; Fairley CK; Bradshaw CS; Chen MY; Chow EPF
    Sex Transm Infect; 2020 Jun; 96(4):246-250. PubMed ID: 31919276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant Utilization of Pre-Exposure Prophylaxis (PrEP) and Meningococcal Vaccine (MenACWY) Among Gay, Bisexual, and Other Men Who Have Sex with Men in Los Angeles County, California.
    Holloway IW; Tan D; Bednarczyk RA; Fenimore VL; Randall L; Lutz CS; Frew PM
    Arch Sex Behav; 2020 Jan; 49(1):137-146. PubMed ID: 31628630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a measure to assess vaccine confidence among men who have sex with men.
    Frew PM; Holloway IW; Goldbeck C; Tan D; Wu E; Jauregui J; Fenimore VL; Randall LA; Lutz CS; Mendel J; Aikin AL; Nowak GJ; Bednarczyk RA
    Expert Rev Vaccines; 2018 Nov; 17(11):1053-1061. PubMed ID: 30433837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Immunization Opinion Leadership among Men Who Have Sex with Men in Los Angeles, California.
    Holloway IW; Bednarczyk R; Fenimore VL; Goldbeck C; Wu E; Himmelstein R; Tan D; Randall L; Lutz CS; Frew PM
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29738508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States.
    Mbaeyi S; Pondo T; Blain A; Yankey D; Potts C; Cohn A; Hariri S; Shang N; MacNeil JR
    JAMA Pediatr; 2020 Sep; 174(9):843-851. PubMed ID: 32687590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal Vaccination in Men Who Have Sex with Men.
    Blackwell CW
    Public Health Nurs; 2017 Mar; 34(2):147-151. PubMed ID: 27921318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine.
    Keshavan P; Pellegrini M; Vadivelu-Pechai K; Nissen M
    Expert Rev Vaccines; 2018 Oct; 17(10):865-880. PubMed ID: 30198805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents.
    Quiambao BP; Jain H; Bavdekar A; Dubey AP; Kolhe D; Bianco V; Van der Wielen M; Miller JM
    Hum Vaccin Immunother; 2016 Aug; 12(8):2162-2168. PubMed ID: 27152501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: an observer-blind, active-controlled, randomised trial.
    Peterson J; Drazan D; Czajka H; Maguire J; Pregaldien JL; Seppa I; Maansson R; O'Neill R; Balmer P; Jodar L; Jansen KU; Anderson AS; Perez JL; Beeslaar J
    Lancet Infect Dis; 2023 Dec; 23(12):1370-1382. PubMed ID: 37579773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: results of an open-label, randomized, phase 3b controlled study in healthy infants.
    Abdelnour A; Silas PE; Lamas MR; Aragón CF; Chiu NC; Chiu CH; Acuña TH; Castrejón Tde L; Izu A; Odrljin T; Smolenov I; Hohenboken M; Dull PM
    Vaccine; 2014 Feb; 32(8):965-72. PubMed ID: 24397906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.
    Graña MG; Cavada G; Vasquez M; Shen J; Maervoet J; Klint J; Gómez JA
    Hum Vaccin Immunother; 2021 Dec; 17(12):5603-5613. PubMed ID: 34890520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial.
    Dbaibo G; El-Ayoubi N; Ghanem S; Hajar F; Bianco V; Miller JM; Mesaros N
    Drugs Aging; 2013 May; 30(5):309-19. PubMed ID: 23494214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal Vaccination Rates Among People With a New Diagnosis of HIV Infection in the US.
    Ghaswalla PK; Marshall GS; Bengtson LGS; Buikema AR; Bancroft T; Koep E; Novy P; Hogea CS
    JAMA Netw Open; 2022 Apr; 5(4):e228573. PubMed ID: 35486405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
    Blain AE; Reese HE; Marjuki H; Topaz N; Mbaeyi S; McNamara LA
    Vaccine; 2021 Dec; 39(52):7541-7544. PubMed ID: 34802785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of fractional dose intradermal injection of two quadrivalent conjugated meningococcal vaccines.
    Jonker EFF; van Ravenhorst MB; Berbers GAM; Visser LG
    Vaccine; 2018 Jun; 36(26):3727-3732. PubMed ID: 29778515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a temporary vaccination recommendation in response to an outbreak of invasive meningococcal serogroup C disease in men who have sex with men in Berlin, 2013-2014.
    Koch J; Hellenbrand W; Schink S; Wichmann O; Carganico A; Drewes J; Kruspe M; Suckau M; Claus H; Marcus U
    Euro Surveill; 2016; 21(5):12-22. PubMed ID: 26877165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.
    Jackson LA; Baxter R; Reisinger K; Karsten A; Shah J; Bedell L; Dull PM;
    Clin Infect Dis; 2009 Jul; 49(1):e1-10. PubMed ID: 19476428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal Disease Surveillance in Men Who Have Sex with Men - United States, 2015-2016.
    Bozio CH; Blain A; MacNeil J; Retchless A; Weil LM; Wang X; Jenkins LT; Rodriguez-Rivera LD; Jarashow C; Ngo V; Hariri S; Mbaeyi SA; Oliver S
    MMWR Morb Mortal Wkly Rep; 2018 Sep; 67(38):1060-1063. PubMed ID: 30260947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.